GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeMD Inc (NAS:LFMD) » Definitions » Cyclically Adjusted PS Ratio

LifeMD (LifeMD) Cyclically Adjusted PS Ratio : 3.75 (As of May. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is LifeMD Cyclically Adjusted PS Ratio?

As of today (2024-05-26), LifeMD's current share price is $7.84. LifeMD's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $2.09. LifeMD's Cyclically Adjusted PS Ratio for today is 3.75.

The historical rank and industry rank for LifeMD's Cyclically Adjusted PS Ratio or its related term are showing as below:

LFMD' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.78   Med: 2.54   Max: 6.63
Current: 3.74

During the past years, LifeMD's highest Cyclically Adjusted PS Ratio was 6.63. The lowest was 0.78. And the median was 2.54.

LFMD's Cyclically Adjusted PS Ratio is ranked worse than
76.76% of 340 companies
in the Healthcare Providers & Services industry
Industry Median: 1.195 vs LFMD: 3.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LifeMD's adjusted revenue per share data for the three months ended in Mar. 2024 was $1.125. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $2.09 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


LifeMD Cyclically Adjusted PS Ratio Historical Data

The historical data trend for LifeMD's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeMD Cyclically Adjusted PS Ratio Chart

LifeMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.77 1.32 4.25

LifeMD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 2.54 3.40 4.25 4.91

Competitive Comparison of LifeMD's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, LifeMD's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeMD's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeMD's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LifeMD's Cyclically Adjusted PS Ratio falls into.



LifeMD Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LifeMD's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=7.84/2.09
=3.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeMD's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, LifeMD's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.125/131.7762*131.7762
=1.125

Current CPI (Mar. 2024) = 131.7762.

LifeMD Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.033 100.560 0.043
201409 0.027 100.428 0.035
201412 0.026 99.070 0.035
201503 0.047 99.621 0.062
201506 0.045 100.684 0.059
201509 0.046 100.392 0.060
201512 0.058 99.792 0.077
201603 0.256 100.470 0.336
201606 0.179 101.688 0.232
201609 0.200 101.861 0.259
201612 0.140 101.863 0.181
201703 0.021 102.862 0.027
201706 0.081 103.349 0.103
201709 0.235 104.136 0.297
201712 0.011 104.011 0.014
201803 0.185 105.290 0.232
201806 0.235 106.317 0.291
201809 0.227 106.507 0.281
201812 0.241 105.998 0.300
201903 0.291 107.251 0.358
201906 0.291 108.070 0.355
201909 0.296 108.329 0.360
201912 0.373 108.420 0.453
202003 0.401 108.902 0.485
202006 0.644 108.767 0.780
202009 0.709 109.815 0.851
202012 0.553 109.897 0.663
202103 0.744 111.754 0.877
202106 0.849 114.631 0.976
202109 0.935 115.734 1.065
202112 0.897 117.630 1.005
202203 0.941 121.301 1.022
202206 0.989 125.017 1.042
202209 1.015 125.227 1.068
202212 0.895 125.222 0.942
202303 1.046 127.348 1.082
202306 1.104 128.729 1.130
202309 1.120 129.860 1.137
202312 1.221 129.419 1.243
202403 1.125 131.776 1.125

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LifeMD  (NAS:LFMD) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LifeMD Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of LifeMD's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeMD (LifeMD) Business Description

Traded in Other Exchanges
N/A
Address
236 Fifth Avenue, Suite 400, Fourth Floor, New York, NY, USA, 10001
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Executives
Bertrand Velge director BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND, ROMNEY MARSH, KENT X0 TN299TR
William J Febbo director, other: Consultant 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Nicholas P Alvarez officer: Chief Acquisition Officer C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Eric Harold Yecies officer: CCO and General Counsel C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Brad Michael Roberts officer: Chief Operating Officer 300 CHAFFORD COURT, SIMPSONVILLE SC 29681
Justin Schreiber director, 10 percent owner, officer: President, Immudyne PR 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Stefan Galluppi director, officer: Chief Operating Officer C/O LIFEMD, INC, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joan Larovere director C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Jessica Friedeman officer: Chief Marketing Officer C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Kathleen E Walsh director C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Piyush Jindal director C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joseph Ditrolio director C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Maria E. Stan officer: Principal Accounting Officer 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Dennis Wijnker officer: Chief Technology Officer 536 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Naveen Bhatia director 823 GREENTREE RD, PACIFIC PALISADES CA 90272